- Tytuł :
- Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.
- Autorzy :
- Źródło :
- Cancer Medicine. Jul2020, Vol. 9 Issue 14, p4991-5007. 17p.
-
Czasopismo naukowe